Copyright
©2013 Baishideng Publishing Group Co.
World J Respirol. Nov 28, 2013; 3(3): 110-115
Published online Nov 28, 2013. doi: 10.5320/wjr.v3.i3.110
Published online Nov 28, 2013. doi: 10.5320/wjr.v3.i3.110
Variables | No. of patients (n = 474) | |
Age (yr) | ||
(median 64) | < 65 | 264 (55.7) |
(range 23-85) | ≥ 65 | 210 (44.3) |
Gender | ||
Male | 323 (68.1) | |
Female | 151 (31.9) | |
Performance status | ||
(ECOG) | 0 | 148 (31.2) |
1 | 240 (50.6) | |
2 | 65 (13.7) | |
3 | 20 (0.04) | |
4 | 1 (0.002) | |
Smoking | ||
Yes | 320 (67.5) | |
No | 154 (32.5) | |
Histology | ||
Adenocarcinoma | 333 (70.3) | |
Non-adenocarcinoma | 141 (29.7) | |
Clinical stage | ||
IIIB | 109 (23.0) | |
IV | 365 (77.0) |
- Citation: Kaira R, Kaira K, Shukuya T, Kenmotsu H, Ono A, Murakami H, Tsuya A, Nakamura Y, Naito T, Endo M, Yamamoto N, Takahashi T. Long-term survival of more than 3 years among patients with advanced non-small cell lung cancer treated with chemotherapy. World J Respirol 2013; 3(3): 110-115
- URL: https://www.wjgnet.com/2218-6255/full/v3/i3/110.htm
- DOI: https://dx.doi.org/10.5320/wjr.v3.i3.110